On 1st March 2022, the NA-ATTC held an interactive workshop in conjunction with Achilles Therapeutics. The workshop was aimed at clinical and non-clinical NHS staff from three NHS delivery sites (The Newcastle upon Tyne Hospitals NHS Foundation Trust, Leeds Teaching Hospital Trust and The Christie NHS Foundation Trust) involved in the procurement of solid tumour tissue sampling for Achilles studies. The workshop facilitated the exchange of ideas, experiences, and common challenges in solid tumour procurement. NA-ATTC believe the importance of ensuring high quality starting material from patients with solid tumours for the manufacture of Advanced Therapy Investigational Medicinal Products is key to the success of novel interventions for cancer.
NA-ATTC found this to be an excellent opportunity for people in different roles such as a Consultant Oncologist, Clinical Trial Coordinators and Nurses to share their experiences. The learnings generated from the workshops will be used to increase the understanding and requirements in site teams for the procurement of solid tumours that can be used to generate a patient-specific product.
Achilles Therapeutics is continuing to work collaboratively with NA-ATTC to help develop learnings to aid the NHS to be institutionally ready for T cell therapies manufactured from solid tumours.
